Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance
Authors:
- 12 November 2016
- journal article
- Published by Wiley in Liver International
- Vol. 37 (5) , 757-764
Abstract
Background & Aims: Drug induced liver injury (DILI) is challenging because of the lack of biomarkers to predict mortality. Our aim was to describe miRNA changes in sera of subjects with acute idiosyncratic DILI and determine if levels of miRNAs were associated with 6 month mortality.Methods: Clinical data and sera were collected from subjects enrolled in the Drug Induced Liver Injury Network prospective study. miRNAs were isolated from serum obtained from 78 subjects within 2 weeks of acute DILI and followed up for 6 months or longer. miRNAs were compared to 40 normal controls and 6 month survivors vs non‐survivors.Results: The mean age of the DILI cohort was 48 years, and 55% were female. Eleven (14.1%) subjects died, 10 within 6 months of DILI onset, 5 (45%) liver related. Lower levels of miRNAs‐122, ‐4463 and ‐4270 were associated with death within 6 months (P<.05). None of the subjects with miRNA‐122 greater than the median value died within 6 months for a sensitivity of 100% and specificity of 57%. In subjects with a serum albumin <2.8 g/dL and miR‐122<7.89 RFU the sensitivity, specificity, positive and negative predictive values for death within 6 months were 100%, 57%, 38% and 100% respectively.Conclusions: Serum miRNA‐122 combined with albumin accurately identified subjects who died within 6 months of drug induced liver injury. If confirmed prospectively, miRNA‐122 and albumin may be useful in identifying patients at high risk for mortality or liver transplantation.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U01‐DK065176, DK065184, DK065193, DK065201, DK065211, DK065238, DK082992, DK083020, DK083023, DK083027, DK100928)
This publication has 34 references indexed in Scilit:
- Prediction of Poor Outcome in Patients with Acute Liver Failure—Systematic Review of Prediction ModelsPLOS ONE, 2012
- Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitisFrontiers in Physiology, 2012
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver DiseasePLOS ONE, 2011
- Circulating microRNAs as potential markers of human drug-induced liver injuryHepatology, 2011
- MicroRNAs in Hepatobiliary and Pancreatic CancersFrontiers in Genetics, 2011
- Drug-Induced Acute Liver FailureHepatology, 2010
- MicroRNAs and the regulation of fibrosisThe FEBS Journal, 2010
- Ago2 Immunoprecipitation Identifies Predicted MicroRNAs in Human Embryonic Stem Cells and Neural PrecursorsPLOS ONE, 2009
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicityHepatology, 2004